Abstract:Background and Aims. Midkine (MDK) is a heparin-binding growth factor and is over expressed in various types of human cancer. However, little is known about the clinical significance of MDK in non-small cell lung cancer (NSCLC). The aim of this study was to measure MDK protein levels in patients with NSCLC and to explore its clinical significance.Methods. The expression status of MDK in NSCLC at Gene Expression Omnibus (GEO accession number: GSE19804) was observed. The expression of MDK mRNA and protein was examined in NSCLC tissues and normal lung tissues through real-time PCR and Western blot. Meanwhile, the relationship of MDK protein expression levels with clinical characteristics of 186 NSCLC patients was analyzed by immunohistochemistry.Results. MDK expression was increased in NSCLC tissues compared with paired normal lung tissues in microarray data (GSE19804). MDK mRNA and protein expression were obviously increased in NSCLC tissues than in paired adjacent normal lung tissues. Using immunohistochemistry, MDK protein overexpression was positively correlated with status of clinical stage, T classification, N classification, and M classification in NSCLC patients. In survival analysis, patients with higher MDK protein expression had a significantly shorter overall survival time than did patients with lower MDK protein expression. Multivariate analysis indicated that the MDK protein overexpression was an independent poor prognostic indicator for patients with NSCLC.Conclusions. MDK plays an important role in NSCLC progression and prognosis and may act as a convincing prognostic indicator for NSCLC patients. (C) 2015 IMSS. Published by Elsevier Inc.

Expression of Midkine and Its Relationship with Cell Proliferation and Apoptosis in Pancreatic Cancer

Clinical significance of Midkine expression in pancreatic carcinoma

Expression of Midkine in Ameloblastomas and Its Correlation with Clinicopathologic Parameters.

MDK Protein Overexpression Correlates with the Malignant Status and Prognosis of Non-small Cell Lung Cancer

Clinical Significance of MK Expression in Gastric Carcinoma

Expression of Midkine and Vascular Endothelial Growth Factor and Their Significances in Gastric Carcinoma

Abnormal expression, highly efficient detection and novel truncations of midkine in human tumors, cancers and cell lines.

Protein expression level of midkine associated with angiogenesis of cervical carcinoma and p4tient's survival

Expression and Significance of Midkine Protein in Non-small-cell-lung Carcinoma

Expression of MK and OPN in Gastric Carcinoma

High Expression of Midkine (MK) Indicates Poor Prognosis in Childhood Acute Lymphoblastic Leukemia.

Expression of midkine and its clinical significance in transitional cell carcinoma of human urinary bladder

Expression of Midkine in Human Glioma and Its Significance

Prognostic Value of Midkine Expression in Patients with Solid Tumors: a Systematic Review and Meta-Analysis

Increased Proliferation Of Human Gastricarcinoma Cell Line Bgc823 Transfected With Midkine And Truncated Midkine Gene

Expression and Significance of Midkine(MK)in Esophageal Squamous Cell Carcinoma and Correlation with Microvessel Density

The Differential Expression of MMP-9 and Ki67 in Pancreatic Cancer

Midkine Is Overexpressed In Acute Pancreatitis And Promotes The Pancreatic Recovery In L-Arginine-Induced Acute Pancreatitis In Mice

Construction of MKK4 Adenovirus and Its Effects on the Proliferation and Invasion of Pancreatic Cancer Cells

Clinical Significance of Midkine Expression in Breast Cancer

Midkine Upregulates Mica/B Expression in Human Gastric Cancer Cells and Decreases Natural Killer Cell Cytotoxicity